He studied aerospace engineering at the University of Washington and worked in mission operations at the National Aeronautics and Space Administration (NASA) in Houston, Texas. Dr. Filbin attended medical school at Baylor College of Medicine and did his residency training in the Harvard-Affiliated Emergency Medicine Residency (HAEMR) program. Dr. Filbin’s research interest is in human clinical trials of septic shock with a particular focus on early identification and intervention. Dr. Filbin is a co-author of the ProCESS trial, a landmark study investigating early initiation of protocolized care in patients with septic shock.